Spots Global Cancer Trial Database for antineoplaston therapy (atengenal + astugenal)
Every month we try and update this database with for antineoplaston therapy (atengenal + astugenal) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma | NCT00003470 | Anaplastic Astr... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus | NCT00003487 | Adenocarcinoma ... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme | NCT00003456 | Glioblastoma Mu... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With High-Grade Stage II - Stage IV Non-Hodgkin's Lymphoma | NCT00003501 | Non-hodgkins Ly... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer | NCT00003489 | Head and Neck C... | Antineoplaston ... | 16 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva | NCT00003525 | Cervical Cancer... Vulvar Cancer, ... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors | NCT00003476 | Childhood Brain... | Antineoplaston ... | 6 Months - 18 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine | NCT00003522 | Small Intestine... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors | NCT00003515 | Primitive Neuro... | Antineoplaston ... | 6 Months - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer | NCT00003494 | Bronchial Alveo... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System | NCT00003469 | Rhabdoid Neopla... | Antineoplaston ... | 6 Months - 17 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma | NCT02988726 | CNS Tumor | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Brain Stem Glioma | NCT00003459 | Brain Stem Glio... | Antineoplaston ... | 6 Months - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Primary Liver Cancer | NCT00003530 | Primary Liver C... | Antineoplaston ... | 14 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Children With Visual Pathway Glioma | NCT00003477 | Visual Pathway ... | Antineoplaston ... | 6 Months - 17 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer | NCT00003489 | Head and Neck C... | Antineoplaston ... | 16 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Ependymoma | NCT00003479 | Ependymoma | Antineoplaston ... | 6 Months - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Meningioma | NCT00003483 | Meningioma | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Adult Patients With Anaplastic Astrocytoma | NCT00003537 | Adult Brain Tum... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma | NCT00003470 | Anaplastic Astr... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System | NCT00003469 | Rhabdoid Neopla... | Antineoplaston ... | 6 Months - 17 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer | NCT00003453 | Stage IV Adreno... | Antineoplaston ... | 6 Months - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma | NCT00003499 | Low-Grade Lymph... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia | NCT00003512 | Waldenstrom Mac... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma | NCT00003508 | Malignant Mesot... | Antineoplaston ... | 1 Year - 120 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Stage IV Melanoma | NCT00003509 | Stage IV Melano... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Intermediate-Grade Stage II - IV Non-Hodgkin's Lymphoma | NCT00003500 | Non-hodgkins Ly... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer | NCT00003454 | Stage IV Breast... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With High-Grade Stage II - Stage IV Non-Hodgkin's Lymphoma | NCT00003501 | Non-hodgkins Ly... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Ependymoma | NCT00003479 | Ependymoma | Antineoplaston ... | 6 Months - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma | NCT00003498 | Non Hodgkin Lym... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG) | NCT02742883 | Diffuse, Intrin... | Antineoplaston ... | 3 Months - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine | NCT00003522 | Small Intestine... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Children With Brain Tumors | NCT00003458 | Childhood Brain... | Antineoplaston ... | 6 Months - 18 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma | NCT00003508 | Malignant Mesot... | Antineoplaston ... | 1 Year - 120 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva | NCT00003525 | Cervical Cancer... Vulvar Cancer, ... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma | NCT00003535 | High Grade Glio... | Antineoplaston ... | 6 Months - 18 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma | NCT00003535 | High Grade Glio... | Antineoplaston ... | 6 Months - 18 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin | NCT00003526 | Unknown Primary... | Antineoplaston ... | 6 Months - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer | NCT00003496 | Small Cell Lung... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine | NCT00003522 | Small Intestine... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer | NCT00003520 | Stage IV Kidney... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer | NCT00003497 | Stage IV Non-sm... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Brain Stem Glioma | NCT00003459 | Brain Stem Glio... | Antineoplaston ... | 6 Months - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors | NCT00003515 | Primitive Neuro... | Antineoplaston ... | 6 Months - 99 Years | Burzynski Research Institute | |
| Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Bladder | NCT00003452 | Stage IV Bladde... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma | NCT00003468 | Low Grade Astro... | Antineoplaston ... | 6 Months - 17 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme | NCT00003474 | Glioblastoma Mu... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer | NCT00003532 | Stage III Ovari... Stage IV Ovaria... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer | NCT00003496 | Small Cell Lung... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Multiple Myeloma | NCT00003511 | Multiple Myelom... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Children With Brain Tumors | NCT00003458 | Childhood Brain... | Antineoplaston ... | 6 Months - 18 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With High-Grade Stage II - Stage IV Non-Hodgkin's Lymphoma | NCT00003501 | Non-hodgkins Ly... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer | NCT00003492 | Stage IV Lung C... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer | NCT00003494 | Bronchial Alveo... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
